Literature DB >> 2461592

Biotherapy of chronic myelogenous leukemia with interferon.

H Ozer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2461592

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  Recombinant human interferons alpha, beta and gamma reduce the antiproliferative action of cytarabine in K562 human myeloid leukaemia clonogenic cells.

Authors:  H R Maurer; H T Hassan; C Tsiriyotis; D A Spandidos
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.

Authors:  W E Aulitzky; C Peschel; D Desprès; J Aman; P Trautman; H Tilg; G Rudolf; H Hüttmann; J Obermeier; M Herold
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

Review 3.  Interferon and chronic myelogenous leukaemia.

Authors:  V M Lauta
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.